
Monica E. Millner
Examiner (ID: 17239, Phone: (571)270-7507 , Office: P/3632 )
| Most Active Art Unit | 3632 |
| Art Unit(s) | 3632, 3508, 3627 |
| Total Applications | 1497 |
| Issued Applications | 1151 |
| Pending Applications | 94 |
| Abandoned Applications | 283 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17104290
[patent_doc_number] => 11124485
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-21
[patent_title] => Deoxyuridine triphosphatase inhibitors containing cyclopropano linkage
[patent_app_type] => utility
[patent_app_number] => 16/773411
[patent_app_country] => US
[patent_app_date] => 2020-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30035
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 490
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16773411
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/773411 | Deoxyuridine triphosphatase inhibitors containing cyclopropano linkage | Jan 26, 2020 | Issued |
Array
(
[id] => 15930961
[patent_doc_number] => 20200157114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => OPTICALLY ACTIVE AZABICYCLO RING DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 16/748191
[patent_app_country] => US
[patent_app_date] => 2020-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28275
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16748191
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/748191 | Optically active azabicyclo ring derivative | Jan 20, 2020 | Issued |
Array
(
[id] => 17407132
[patent_doc_number] => 11248001
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-15
[patent_title] => PCSK9 inhibitors and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/744929
[patent_app_country] => US
[patent_app_date] => 2020-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69319
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16744929
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/744929 | PCSK9 inhibitors and methods of use thereof | Jan 15, 2020 | Issued |
Array
(
[id] => 18237576
[patent_doc_number] => 20230069886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => AROMATIC SULPHONAMIDES DERIVATIVES THAT INHIBITS PDI A3, THEIR SYNTHESIS AND USE
[patent_app_type] => utility
[patent_app_number] => 17/791657
[patent_app_country] => US
[patent_app_date] => 2020-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16206
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17791657
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/791657 | AROMATIC SULPHONAMIDES DERIVATIVES THAT INHIBITS PDI A3, THEIR SYNTHESIS AND USE | Jan 9, 2020 | Pending |
Array
(
[id] => 16948028
[patent_doc_number] => 20210206719
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => AMINO ALCOHOL-BORON-BINOL COMPLEX AND METHOD FOR PREPARING OPTICALLY ACTIVE AMINO ALCOHOL DERIVATIVE BY USING SAME
[patent_app_type] => utility
[patent_app_number] => 16/740083
[patent_app_country] => US
[patent_app_date] => 2020-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8344
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 389
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16740083
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/740083 | Amino alcohol-boron-binol complex and method for preparing optically active amino alcohol derivative by using same | Jan 9, 2020 | Issued |
Array
(
[id] => 16962839
[patent_doc_number] => 20210214338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => 1,3-DIPOLAR CYCLOADDITIONS, AND STAUDINGER LIGATIONS FOR CONJUGATING BIOMOLECULES USING CLICK CHEMISTRY
[patent_app_type] => utility
[patent_app_number] => 16/740153
[patent_app_country] => US
[patent_app_date] => 2020-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21598
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16740153
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/740153 | 1,3-dipolar cycloadditions, and Staudinger ligations for conjugating biomolecules using click chemistry | Jan 9, 2020 | Issued |
Array
(
[id] => 16735810
[patent_doc_number] => 10961447
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-30
[patent_title] => Light emitting material, manufacture method thereof and organic light emitting diode using the light emitting material
[patent_app_type] => utility
[patent_app_number] => 16/737913
[patent_app_country] => US
[patent_app_date] => 2020-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3889
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16737913
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/737913 | Light emitting material, manufacture method thereof and organic light emitting diode using the light emitting material | Jan 8, 2020 | Issued |
Array
(
[id] => 17697067
[patent_doc_number] => 11370777
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-28
[patent_title] => Solid forms comprising (s)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile and salts thereof, and compositions comprising and methods of using the same
[patent_app_type] => utility
[patent_app_number] => 16/737739
[patent_app_country] => US
[patent_app_date] => 2020-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 80
[patent_figures_cnt] => 171
[patent_no_of_words] => 98884
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16737739
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/737739 | Solid forms comprising (s)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile and salts thereof, and compositions comprising and methods of using the same | Jan 7, 2020 | Issued |
Array
(
[id] => 16120589
[patent_doc_number] => 20200212317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => P-TYPE ORGANIC SEMICONDUCTOR, COMPOSITION, PHOTOELECTRIC CONVERSION FILM, PHOTOELECTRIC CONVERSION DEVICE, AND IMAGE SENSOR
[patent_app_type] => utility
[patent_app_number] => 16/726416
[patent_app_country] => US
[patent_app_date] => 2019-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6231
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16726416
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/726416 | P-type organic semiconductor, composition, photoelectric conversion film, photoelectric conversion device, and image sensor | Dec 23, 2019 | Issued |
Array
(
[id] => 16086809
[patent_doc_number] => 20200197391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/723438
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 79121
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16723438
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/723438 | COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF | Dec 19, 2019 | Abandoned |
Array
(
[id] => 15800051
[patent_doc_number] => 20200123168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-23
[patent_title] => MORPHIC FORMS OF G1T38 AND METHODS OF MANUFACTURE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/721631
[patent_app_country] => US
[patent_app_date] => 2019-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30833
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16721631
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/721631 | Morphic forms of G1T38 and methods of manufacture thereof | Dec 18, 2019 | Issued |
Array
(
[id] => 17497551
[patent_doc_number] => 11286243
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-29
[patent_title] => Ferroportin inhibitors and methods of use
[patent_app_type] => utility
[patent_app_number] => 16/712628
[patent_app_country] => US
[patent_app_date] => 2019-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52878
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 369
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16712628
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/712628 | Ferroportin inhibitors and methods of use | Dec 11, 2019 | Issued |
Array
(
[id] => 15740481
[patent_doc_number] => 20200109128
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-09
[patent_title] => PYRAZINE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 16/710035
[patent_app_country] => US
[patent_app_date] => 2019-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51797
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16710035
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/710035 | Pyrazine compound | Dec 10, 2019 | Issued |
Array
(
[id] => 15768705
[patent_doc_number] => 20200115370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-16
[patent_title] => SELECTIVE NR2B ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 16/707382
[patent_app_country] => US
[patent_app_date] => 2019-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13834
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16707382
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/707382 | Selective NR2B antagonists | Dec 8, 2019 | Issued |
Array
(
[id] => 17044862
[patent_doc_number] => 11098030
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-24
[patent_title] => EGFR inhibitor compounds
[patent_app_type] => utility
[patent_app_number] => 16/703544
[patent_app_country] => US
[patent_app_date] => 2019-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22702
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16703544
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/703544 | EGFR inhibitor compounds | Dec 3, 2019 | Issued |
Array
(
[id] => 18801265
[patent_doc_number] => 11834416
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-05
[patent_title] => Cleavable agents
[patent_app_type] => utility
[patent_app_number] => 16/698332
[patent_app_country] => US
[patent_app_date] => 2019-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 5195
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16698332
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/698332 | Cleavable agents | Nov 26, 2019 | Issued |
Array
(
[id] => 16853359
[patent_doc_number] => 20210154104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => SUBSTANCES AND METHODS FOR BEDSIDE MANAGEMENT OF POST-OPERATIVE PAIN
[patent_app_type] => utility
[patent_app_number] => 16/693232
[patent_app_country] => US
[patent_app_date] => 2019-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3334
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16693232
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/693232 | SUBSTANCES AND METHODS FOR BEDSIDE MANAGEMENT OF POST-OPERATIVE PAIN | Nov 22, 2019 | Abandoned |
Array
(
[id] => 17520440
[patent_doc_number] => 20220106289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => NLRP3 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/296151
[patent_app_country] => US
[patent_app_date] => 2019-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48312
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17296151
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/296151 | NLRP3 INHIBITORS | Nov 21, 2019 | Abandoned |
Array
(
[id] => 16398707
[patent_doc_number] => 20200339565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => PRODRUG SUBSTITUTED POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 16/684870
[patent_app_country] => US
[patent_app_date] => 2019-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 149530
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16684870
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/684870 | PRODRUG SUBSTITUTED POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVE | Nov 14, 2019 | Abandoned |
Array
(
[id] => 17756218
[patent_doc_number] => 11396502
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-26
[patent_title] => Substituted heterocyclic derivatives as PI3K inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/681267
[patent_app_country] => US
[patent_app_date] => 2019-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60775
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 4585
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16681267
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/681267 | Substituted heterocyclic derivatives as PI3K inhibitors | Nov 11, 2019 | Issued |